• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mechanisms of post-intervention arterial remodelling.介入治疗后动脉重塑的机制。
Cardiovasc Res. 2012 Dec 1;96(3):363-71. doi: 10.1093/cvr/cvs276. Epub 2012 Aug 22.
2
Do statins have a role in reduction/prevention of post-PCI restenosis?他汀类药物在减少/预防 PCI 后再狭窄中有作用吗?
Cardiovasc Ther. 2013 Feb;31(1):12-26. doi: 10.1111/j.1755-5922.2011.00302.x. Epub 2011 Oct 3.
3
Unusually aggressive immature neo-intimal hyperplasia causing in-stent restenosis.异常侵袭性的不成熟新生内膜增生导致支架内再狭窄。
Cardiovasc J Afr. 2017;28(6):404-405. doi: 10.5830/CVJA-2017-024. Epub 2017 Oct 10.
4
Preventing restenosis after angioplasty: a multistage approach.血管成形术后预防再狭窄:一种多阶段方法。
Clin Sci (Lond). 2008 Feb;114(4):257-64. doi: 10.1042/CS20070228.
5
In-stent restenosis: surgical and histopathological perspective.支架内再狭窄:外科手术及组织病理学视角
Asian Cardiovasc Thorac Ann. 2018 Feb;26(2):114-119. doi: 10.1177/0218492318754741. Epub 2018 Jan 22.
6
Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells.小型猪冠状动脉再狭窄组织的二维荧光凝胶电泳:脂肪细胞脂肪酸结合蛋白增加诱导平滑肌细胞内活性氧介导的生长和迁移。
Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):572-80. doi: 10.1161/ATVBAHA.112.301016. Epub 2013 Jan 31.
7
Revisiting the Evidence for Dipyridamole in Reducing Restenosis: A Systematic Review and Meta-analysis.重新审视双嘧达莫减少再狭窄的证据:系统评价和荟萃分析。
J Cardiovasc Pharmacol. 2021 Apr 1;77(4):450-457. doi: 10.1097/FJC.0000000000000976.
8
Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge.药物洗脱支架置入后新生动脉粥样硬化:一种新的临床和治疗挑战。
Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):105-116. doi: 10.1093/ehjcvp/pvy036.
9
INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.OCT 评价药物涂层球囊与金属裸支架治疗初发冠状动脉病变的内膜增生(IN-PACT CORO):一项随机对照试验的研究方案。
Trials. 2012 May 6;13:55. doi: 10.1186/1745-6215-13-55.
10
Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.糖尿病患者接受依维莫司洗脱支架和西罗莫司洗脱支架植入后的内膜增生与血管重塑:随机糖尿病与药物洗脱支架(DiabeDES)IV血管内超声试验
Catheter Cardiovasc Interv. 2014 May 1;83(6):864-72. doi: 10.1002/ccd.25180. Epub 2013 Sep 30.

引用本文的文献

1
Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.用于冠状动脉疾病的药物涂层球囊:从理论到实践
Curr Treat Options Cardiovasc Med. 2025 Dec;27(1). doi: 10.1007/s11936-025-01084-4. Epub 2025 Mar 19.
2
Beyond cancer: The potential application of CD47-based therapy in non-cancer diseases.超越癌症:基于CD47的疗法在非癌症疾病中的潜在应用。
Acta Pharm Sin B. 2025 Feb;15(2):757-791. doi: 10.1016/j.apsb.2024.11.018. Epub 2024 Nov 28.
3
Cucurbitacins mitigate vascular neointimal hyperplasia by suppressing cyclin A2 expression and inhibiting VSMC proliferation.葫芦素通过抑制细胞周期蛋白 A2 的表达和抑制 VSMC 增殖来减轻血管新生内膜增生。
Animal Model Exp Med. 2024 Aug;7(4):397-407. doi: 10.1002/ame2.12457. Epub 2024 Jul 5.
4
Neointimal hyperplasia after endoluminal injury in mice is dependent on tissue factor- and angiopoietin-2 dependent interferon gamma production by fibrocytes and macrophages.小鼠血管内损伤后新生内膜增生依赖于成纤维细胞和巨噬细胞的组织因子和血管生成素-2 依赖性干扰素 γ的产生。
Front Immunol. 2024 Jun 7;15:1345199. doi: 10.3389/fimmu.2024.1345199. eCollection 2024.
5
Dynamin-related protein 1 mediates the therapeutic effect of isoliquiritigenin in diabetic intimal hyperplasia via regulation of mitochondrial fission.DRP1 通过调节线粒体分裂介导甘草素在糖尿病内膜增生中的治疗作用。
Hypertens Res. 2024 Jul;47(7):1908-1924. doi: 10.1038/s41440-024-01681-z. Epub 2024 May 15.
6
Cholesteryl Hemiazelate Present in Cardiovascular Disease Patients Causes Lysosome Dysfunction in Murine Fibroblasts.胆固醇酰基溶血磷脂酸存在于心血管疾病患者中,导致小鼠成纤维细胞溶酶体功能障碍。
Cells. 2023 Dec 13;12(24):2826. doi: 10.3390/cells12242826.
7
Impact of the transforming growth factor-β pathway on vascular restenosis and its mechanism.转化生长因子-β 通路对血管再狭窄的影响及其机制。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Aug 28;48(8):1252-1259. doi: 10.11817/j.issn.1672-7347.2023.230064.
8
Medical and Surgical Management of Symptomatic and Asymptomatic Carotid Artery Stenosis: A Comprehensive Literature Review.有症状和无症状颈动脉狭窄的医学与外科治疗:一项全面的文献综述
Cureus. 2023 Aug 10;15(8):e43263. doi: 10.7759/cureus.43263. eCollection 2023 Aug.
9
Experimental Liver Cirrhosis Inhibits Restenosis after Balloon Angioplasty.实验性肝硬化抑制球囊血管成形术后再狭窄。
Int J Mol Sci. 2023 Jul 12;24(14):11351. doi: 10.3390/ijms241411351.
10
Associations between preprocedural carotid artery perivascular fat density and early in-stent restenosis after carotid artery stenting.颈动脉支架置入术前颈动脉血管周围脂肪密度与早期支架内再狭窄之间的关联。
Heliyon. 2023 May 25;9(6):e16220. doi: 10.1016/j.heliyon.2023.e16220. eCollection 2023 Jun.

本文引用的文献

1
Myofibroblast-mediated adventitial remodeling: an underestimated player in arterial pathology.肌成纤维细胞介导的血管外膜重构:动脉病理学中被低估的角色。
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2391-6. doi: 10.1161/ATVBAHA.111.231548.
2
Crucial vasculoprotective role of the whole nitric oxide synthase system in vascular lesion formation in mice: Involvement of bone marrow-derived cells.整个一氧化氮合酶系统在小鼠血管病变形成中的关键血管保护作用:涉及骨髓来源的细胞。
Nitric Oxide. 2011 Oct 30;25(3):350-9. doi: 10.1016/j.niox.2011.06.007. Epub 2011 Jul 13.
3
TGF-β and restenosis revisited: a Smad link.TGF-β 与再狭窄再探讨:一个 Smad 联系。
J Surg Res. 2011 May 15;167(2):287-97. doi: 10.1016/j.jss.2010.12.020. Epub 2011 Jan 15.
4
Proteins mediating collagen biosynthesis and accumulation in arterial repair: novel targets for anti-restenosis therapy.介导动脉修复中胶原生物合成和积累的蛋白质:抗再狭窄治疗的新靶点。
Cardiovasc Res. 2011 Jul 1;91(1):16-26. doi: 10.1093/cvr/cvr012. Epub 2011 Jan 18.
5
Role of myofibroblasts in vascular remodelling: focus on restenosis and aneurysm.肌成纤维细胞在血管重构中的作用:关注再狭窄和动脉瘤。
Cardiovasc Res. 2010 Dec 1;88(3):395-405. doi: 10.1093/cvr/cvq224. Epub 2010 Jul 8.
6
Insulin-like growth factor-1 protects from vascular stenosis and accelerates re-endothelialization in a rat model of carotid artery injury.胰岛素样生长因子-1 可预防大鼠颈动脉损伤模型中的血管狭窄并加速再内皮化。
J Thromb Haemost. 2009 Nov;7(11):1920-8. doi: 10.1111/j.1538-7836.2009.03607.x. Epub 2009 Sep 9.
7
Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF.转化生长因子-β信号蛋白Smad3的动脉基因转移可诱导血管成形术后的适应性重塑:结缔组织生长因子的作用。
Cardiovasc Res. 2009 Nov 1;84(2):326-35. doi: 10.1093/cvr/cvp220. Epub 2009 Jul 1.
8
TGF-beta signaling in atherosclerosis and restenosis.转化生长因子-β信号通路在动脉粥样硬化和再狭窄中的作用
Front Biosci (Schol Ed). 2009 Jun 1;1(1):236-45. doi: 10.2741/s23.
9
Fibronectin is an important regulator of flow-induced vascular remodeling.纤连蛋白是血流诱导的血管重塑的重要调节因子。
Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1074-9. doi: 10.1161/ATVBAHA.108.181081. Epub 2009 Apr 30.
10
ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries.ADAMTS-7介导球囊损伤大鼠动脉中的血管平滑肌细胞迁移和新生内膜形成。
Circ Res. 2009 Mar 13;104(5):688-98. doi: 10.1161/CIRCRESAHA.108.188425. Epub 2009 Jan 22.

介入治疗后动脉重塑的机制。

Mechanisms of post-intervention arterial remodelling.

机构信息

Department of Surgery, University of Wisconsin, 1111 Highland Ave., Madison, WI 53705, USA.

出版信息

Cardiovasc Res. 2012 Dec 1;96(3):363-71. doi: 10.1093/cvr/cvs276. Epub 2012 Aug 22.

DOI:10.1093/cvr/cvs276
PMID:22918976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3500049/
Abstract

It has been appreciated over the past two decades that arterial remodelling, in addition to intimal hyperplasia, contributes significantly to the degree of restenosis that develops following revascularization procedures. Remodelling appears to be an adventitia-based process that is contributed to by multiple factors including cytokines and growth factors that regulate extracellular matrix or phenotypic transformation of vascular cells including myofibroblasts. In this review, we summarize the currently available information from animal models as well as clinical investigations regarding arterial remodelling. The factors that contribute to this process are presented with an emphasis on potential therapeutic methods to enhance favourable remodelling and prevent restenosis.

摘要

在过去的二十年中,人们已经认识到,除内膜增生外,动脉重构对血管再通术后再狭窄的程度有重要影响。重构似乎是一种基于血管外膜的过程,由多种因素共同作用,包括调节细胞外基质的细胞因子和生长因子,以及血管细胞(包括平滑肌细胞)的表型转化。在这篇综述中,我们总结了目前在动物模型和临床研究中关于动脉重构的信息。本文重点介绍了促进有利重构和预防再狭窄的潜在治疗方法。